Table 3.
Measures of nocturnal hypoxemia | ||||||
---|---|---|---|---|---|---|
ODI (4%, events/h; TRT) |
P-value | Mean SpO2 (TRT) |
P-value | T90 (% TRT) |
P-value | |
eGFR (mL/min/1.73 m²) | −0.06 (−0.11 to −0.02) |
.010 | 0.04 (−0.01 to 0.08) |
.160 | −0.05 (−0.10 to 0.002) |
.057 |
Log ACR (mg/mmol) | 0.10 (0.04 to 0.15) |
.001 | −0.09 (−0.15 to −0.03) |
.002 | 0.03 (−0.03 to 0.09) |
.331 |
Beta coefficients adjusted for age, sex, body mass index (BMI) >30 kg/m2, excessive daytime sleepiness (ESS > 10), poor sleep quality (PSQI > 5), smoking, history of kidney disease, proteinuria, hypertension, high cholesterol, diabetes, coronary artery disease, heart failure, atrial fibrillation, stroke, and use of non-steroidal anti-inflammatory (NSAID) and proton pump inhibitor (PPI) medications.